Literature DB >> 25153340

Spread of vaccinia virus to cattle herds, Argentina, 2011.

Ana Paula Moreira Franco-Luiz, Alexandre Fagundes-Pereira, Galileu Barbosa Costa, Pedro Augusto Alves, Danilo Bretas Oliveira, Cláudio Antônio Bonjardim, Paulo César Peregrino Ferreira, Giliane de Souza Trindade, Carlos Javier Panei, Cecilia Mónica Galosi, Jônatas Santos Abrahão, Erna Geessien Kroon.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25153340      PMCID: PMC4178398          DOI: 10.3201/eid2009.140154

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Since 1999, several zoonotic outbreaks of vaccinia virus (VACV) infection have been reported in cattle and humans in rural areas of Brazil. The infections have caused exanthematous lesions on cows and persons who milk them, and thus are detrimental to the milk industry and public health services (,). In Brazil during the last decade, VACV outbreaks have been detected from the north to the extreme south of the country (–). Because Brazil shares extensive boundaries with other South American countries, humans and cattle on dairy and beef-producing farms in those countries may be at risk of exposure to VACV. To determine if VACV has spread from Brazil to Argentina, we investigated the presence of VACV in serum samples from cattle in Argentina. During 2011, we obtained serum samples from 100 animals (50 dairy and 50 beef cattle) on farms in Córdoba, Corrientes, Entre Ríos, and Santa Fe Provinces in Argentina (Technical Appendix, panel A). No VACV cases had been reported in humans or cattle in these provinces. However, Corrientes Province borders the Brazilian state of Rio Grande do Sul, where VACVs (Pelotas 1 and Pelotas 2 viruses) were isolated during an outbreak affecting horses in 2008 (). To determine the presence of neutralizing antibodies in the serum samples, we used an orthopoxvirus 70% plaque-reduction neutralization test as described (). On the basis of previous studies that detected viral DNA in serum samples (–), we used real-time PCR to amplify the highly conserved orthopoxvirus vaccinia growth factor (vgf) gene DNA (P.A. Alves, unpub. methods). To amplify the hemagglutinin (HA) gene DNA from the serum samples, we used real-time PCR with primers as described by de Souza Trindade et al. 2008 (). The HA PCR products were directly sequenced in both orientations by using specific primers and capillary electrophoresis (Genetic Analyzer 3130; Applied Biosystems, Grand Island, NY, USA). We used ClustalW (http://www.clustal.org) and MEGA4 software (http://megasoftware.net/) to align nucleotide sequences and construct a phylogenetic tree (neighbor-joining method, 1,000 bootstraps) from the obtained HA fragment. Of the 50 dairy cattle samples, 4 (8.0%) had neutralizing antibodies against orthopoxvirus; of these, 3 (75.0%) had titers of 100 neutralizing units (NU)/mL, and 1 (25.0%) had a titer of 400 NU/mL. Of the 50 beef cattle, 8 (16.0%) had antibodies to orthopoxvirus, 1 (12.5%) of which had a titer of 800 NU/mL. Most of the positive samples were from cattle in Corrientes and Entre Ríos Provinces (Table).
Table

Diagnosis of Orthopoxvirus infection in beef and dairy cattle during a study of the spread of vaccinia virus to cattle herds, Argentina, 2011*

ProvinceCattle typeNo. farms sampledNo. serum samples testedNo. positive samples, by level of NU/mL against orthopoxvirus†
No. (%) positive by real-time PCR
100200400800Total (%) vgf HA
CórdobaDairy12500101 (4.0)2 (8.0)0
Santa FeDairy12530003 (12.0)00
CorrientesBeef>2‡801102 (25.0)1 (12,5)§1 (12,5)§
Entre RíosBeef54222116 (14.3)2 (4,8)1 (2,4)§
TotalDairy and beef>9100533112 (12.0)5 (5.0)2 (2.0)

*HA, hemagglutinin gene DNA; NU, serum dilution at which 70% plaque reduction per mL occurs; vgf, orthopoxvirus vaccinia growth factor gene DNA.
†Determined by plaque-reduction neutralization test.
‡Samples were obtained from several farms in Corrientes Province.
§Animal was also positive by plaque-reduction neutralization test.

*HA, hemagglutinin gene DNA; NU, serum dilution at which 70% plaque reduction per mL occurs; vgf, orthopoxvirus vaccinia growth factor gene DNA.
†Determined by plaque-reduction neutralization test.
‡Samples were obtained from several farms in Corrientes Province.
§Animal was also positive by plaque-reduction neutralization test. Of the 100 serum samples, 5 (3 from beef and 2 from dairy cattle) were positive for vgf by real-time PCR. HA DNA was amplified from 2 of the 3 vgf PCR–positive beef cattle samples; plaque-reduction neutralization test results were also positive for the 2 samples (Table). Alignment of the HA fragment nucleotide sequence of the isolates from Argentina showed that the sequence was highly similar to that of the homologous gene of VACV isolates from Brazil. Furthermore, the sequences showed a signature deletion that is also present in the sequences of VACV isolates from Brazil. Compared with sequences for other VACV isolates, those from Argentina had 2 polymorphisms (Technical Appendix, panel C). The HA sequences from the isolates from Argentina demonstrated 100% identity among themselves and exhibited higher identity with group 1 (98.2% identity) versus group 2 (93.6% identity) isolates from Brazil (Technical Appendix, panel D). In the phylogenetic tree based on the HA nucleotide sequences (Technical Appendix, panel B), the VACVs from Argentina clustered with several group 1 VACVs detected during outbreaks in Brazil. Although no outbreaks of exanthematous VACV infection have been described in cattle or humans in Argentina, we detected neutralizing antibodies against orthopoxvirus and detected VACV DNA in serum samples from cattle in the country. Most of the seropositive samples were from cattle in Entre Ríos Province, which shares a border with Uruguay, and Corrientes Province, which shares a border with Rio Grande do Sul State in Brazil, where Pelotas VACVs have been isolated (). We believe that the seropositive cattle in this study may have been exposed to VACV, the only orthopoxvirus known to be circulating in South America (–,–). Despite veterinary surveillance efforts of border control organizations, VACV control may be hampered by the circulation of infected rural workers and the misdiagnosis of VACV infection; misdiagnoses occur because VACV lesions resemble those of other exanthematous diseases. Moreover, peridomestic rodents have been hypothesized to act as VACV hosts, and could facilitate the spread of VACV in border areas (). In addition, we could not rule out the circulation of autochthonous VACV in Argentina, but this is a less likely explanation. Our findings suggest that cattle herds in areas of Argentina near the border with Brazil may be exposed to VACV from Brazil and, thus, may be at risk for VACV infection. Further research is needed to determine the risk factors for VACV infection and to assess the circulation of VACV in South America

Technical Appendix

Map of Argentina, indicating locations where blood samples were collected from cattle and results of phylogenetic analysis of vaccine virus isolated from the samples.
  9 in total

1.  Seroprevalence of orthopoxvirus in an Amazonian rural village, Acre, Brazil.

Authors:  B E F Mota; G S Trindade; T C Diniz; M da Silva-Nunes; E M Braga; M Urbano-Ferreira; G O L Rodrigues; C A Bonjardim; P C P Ferreira; E G Kroon
Journal:  Arch Virol       Date:  2010-04-29       Impact factor: 2.574

2.  Detection of vaccinia DNA in the blood following smallpox vaccination.

Authors:  Michael R Savona; Wilfred P Dela Cruz; Morris S Jones; Jennifer A Thornton; Dongxiang Xia; Ted L Hadfield; Patrick J Danaher
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

3.  Short report: Isolation of two vaccinia virus strains from a single bovine vaccinia outbreak in rural area from Brazil: Implications on the emergence of zoonotic orthopoxviruses.

Authors:  Giliane S Trindade; Zélia I P Lobato; Betânia P Drumond; Juliana A Leite; Ricardo C Trigueiro; Maria I M C Guedes; Flávio G da Fonseca; João R dos Santos; Cláudio A Bonjardim; Paulo C P Ferreira; Erna G Kroon
Journal:  Am J Trop Med Hyg       Date:  2006-09       Impact factor: 2.345

4.  Assessing the variability of Brazilian Vaccinia virus isolates from a horse exanthematic lesion: coinfection with distinct viruses.

Authors:  Rafael K Campos; Mário C S Brum; Carlos E W Nogueira; Betânia P Drumond; Pedro A Alves; Larissa Siqueira-Lima; Felipe L Assis; Giliane S Trindade; Cláudio A Bonjardim; Paulo C Ferreira; Rudi Weiblen; Eduardo F Flores; Erna G Kroon; Jônatas S Abrahão
Journal:  Arch Virol       Date:  2010-11-16       Impact factor: 2.574

5.  Detection of vaccinia virus DNA, but not infectious virus, in the blood of smallpox vaccine recipients.

Authors:  Jeffrey I Cohen; Patricia Hohman; Jeanne C Preuss; Li Li; Steven H Fischer; Daniel P Fedorko
Journal:  Vaccine       Date:  2007-04-18       Impact factor: 3.641

6.  Real-time PCR assay to identify variants of Vaccinia virus: implications for the diagnosis of bovine vaccinia in Brazil.

Authors:  Giliane de Souza Trindade; Yu Li; Victoria A Olson; Ginny Emerson; Russell L Regnery; Flavio Guimaraes da Fonseca; Erna Geessien Kroon; Inger Damon
Journal:  J Virol Methods       Date:  2008-07-03       Impact factor: 2.014

7.  Vaccinia virus infection in monkeys, Brazilian Amazon.

Authors:  Jônatas S Abrahão; André T Silva-Fernandes; Larissa S Lima; Rafael K Campos; Maria I M C Guedes; Marcela M G Cota; Felipe L Assis; Iara A Borges; Milton F Souza-Júnior; Zélia I P Lobato; Cláudio A Bonjardim; Paulo C P Ferreira; Giliane S Trindade; Erna G Kroon
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

8.  One more piece in the VACV ecological puzzle: could peridomestic rodents be the link between wildlife and bovine vaccinia outbreaks in Brazil?

Authors:  Jônatas S Abrahão; Maria Isabel M Guedes; Giliane S Trindade; Flávio G Fonseca; Rafael K Campos; Bruno F Mota; Zélia I P Lobato; André T Silva-Fernandes; Gisele O L Rodrigues; Larissa S Lima; Paulo C P Ferreira; Cláudio A Bonjardim; Erna G Kroon
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

9.  Brazilian vaccinia viruses and their origins.

Authors:  Giliane S Trindade; Ginny L Emerson; Darin S Carroll; Erna G Kroon; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

  9 in total
  10 in total

1.  Educational Approach to Prevent the Burden of Vaccinia Virus Infections in a Bovine Vaccinia Endemic Area in Brazil.

Authors:  Galileu Barbosa Costa; Jaqueline Silva de Oliveira; Michael B Townsend; William C Carson; Iara Apolinário Borges; Andrea M McCollum; Erna Geessien Kroon; Panayampalli Subbian Satheshkumar; Mary G Reynolds; Yoshinori J Nakazawa; Giliane de Souza Trindade
Journal:  Pathogens       Date:  2021-04-23

2.  Seroprevalence of bovine vaccinia in cows and its correlation with the productive profile of affected farms in Distrito Federal, Brazil.

Authors:  Lorena Ferreira Silva; Stephan Alberto Machado de Oliveira; Ana Lourdes Arrais de Alencar Mota; Vitor Salvador Picão Gonçalves; Carolina de Oliveira Freitas; Juliana Felipetto Cargnelutti; Eduardo Furtado Flores; Fabiano José Ferreira de Sant'Ana
Journal:  Braz J Microbiol       Date:  2021-11-02       Impact factor: 2.476

3.  Detection of Vaccinia Virus in Dairy Cattle Serum Samples from 2009, Uruguay.

Authors:  Ana Paula Moreira Franco-Luiz; Danilo Bretas Oliveira; Alexandre Fagundes Pereira; Mirela Cristina Soares Gasparini; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Giliane de Souza Trindade; Rodrigo Puentes; Agustin Furtado; Jônatas Santos Abrahão; Erna Geessien Kroon
Journal:  Emerg Infect Dis       Date:  2016-12       Impact factor: 6.883

4.  A Model to Detect Autochthonous Group 1 and 2 Brazilian Vaccinia virus Coinfections: Development of a qPCR Tool for Diagnosis and Pathogenesis Studies.

Authors:  Rafael Calixto; Graziele Oliveira; Maurício Lima; Ana Cláudia Andrade; Giliane de Souza Trindade; Danilo Bretas de Oliveira; Erna Geessien Kroon
Journal:  Viruses       Date:  2017-12-30       Impact factor: 5.048

Review 5.  Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly.

Authors:  Jaqueline Silva de Oliveira; Poliana de Oliveira Figueiredo; Galileu Barbosa Costa; Felipe Lopes de Assis; Betânia Paiva Drumond; Flávio Guimarães da Fonseca; Maurício Lacerda Nogueira; Erna Geessien Kroon; Giliane de Souza Trindade
Journal:  Viruses       Date:  2017-11-15       Impact factor: 5.048

Review 6.  Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.

Authors:  Jonas D Albarnaz; Alice A Torres; Geoffrey L Smith
Journal:  Viruses       Date:  2018-02-28       Impact factor: 5.048

7.  Detection and Molecular Characterization of Zoonotic Poxviruses Circulating in the Amazon Region of Colombia, 2014.

Authors:  Jose A Usme-Ciro; Andrea Paredes; Diana M Walteros; Erica Natalia Tolosa-Pérez; Katherine Laiton-Donato; Maria Del Carmen Pinzón; Brett W Petersen; Nadia F Gallardo-Romero; Yu Li; Kimberly Wilkins; Whitni Davidson; Jinxin Gao; Nishi Patel; Yoshinori Nakazawa; Mary G Reynolds; P S Satheshkumar; Ginny L Emerson; Andrés Páez-Martínez
Journal:  Emerg Infect Dis       Date:  2017-04       Impact factor: 6.883

Review 8.  Bovine Vaccinia: Insights into the Disease in Cattle.

Authors:  Ana Carolina Diniz Matos; Izabelle Silva Rehfeld; Maria Isabel Maldonado Coelho Guedes; Zélia Inês Portela Lobato
Journal:  Viruses       Date:  2018-03-09       Impact factor: 5.048

9.  An Update on the Known Host Range of the Brazilian Vaccinia Virus: An Outbreak in Buffalo Calves.

Authors:  Mauricio Teixeira Lima; Graziele Pereira Oliveira; José Augusto Bastos Afonso; Rodolfo José Cavancanti Souto; Carla Lopes de Mendonça; Antonio Flavio Medeiros Dantas; Jonatas Santos Abrahao; Erna Geessien Kroon
Journal:  Front Microbiol       Date:  2019-01-22       Impact factor: 5.640

Review 10.  Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?

Authors:  Iago José da Silva Domingos; Jaqueline Silva de Oliveira; Kamila Lorene Soares Rocha; Danilo Bretas de Oliveira; Erna Geessien Kroon; Galileu Barbosa Costa; Giliane de Souza Trindade
Journal:  Pathogens       Date:  2021-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.